Discovery and development of gliflozins: Difference between revisions
Line 107: | Line 107: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
! Compound !! IC<sub>50</sub> (nM) | ! Compound !! IC<sub>50</sub> (nM) | ||
|- | |- | ||
|align="center"| [[File:Mynd fyrir toflu3-1.png]] ||align="center"| 0.720 | |align="center"| [[File:Mynd fyrir toflu3-1.png]] ||align="center"| 0.720 |